AJP - GI Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 293: G19-G24, 2007. First published March 29, 2007; doi:10.1152/ajpgi.00055.2007
0193-1857/07 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/1/G19    most recent
00055.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Souza, R. F.
Right arrow Articles by Spechler, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Souza, R. F.
Right arrow Articles by Spechler, S. J.

TRANSLATIONAL PHYSIOLOGY

GERD is associated with shortened telomeres in the squamous epithelium of the distal esophagus

Rhonda F. Souza,1,4 Tisha Lunsford,6 Ruben D. Ramirez,1,5,4 Xi Zhang,1 Edward L. Lee,7 Yuenan Shen,2 Charles Owen,1 Jerry W. Shay,3 Carmela Morales,8 and Stuart Jon Spechler1,4

Departments of 1Medicine, 2Pathology, and 3Cell Biology, University of Texas Southwestern Medical Center at Dallas and the 4Veterans Affairs North Texas Health Center, the Harold C. Simmons Comprehensive Cancer Center, 5Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center at Dallas, Dallas; 6Division of Gastroenterology, Mayo Clinic, Scottsdale, Arizona; 7Department of Pathology, Howard University College of Medicine, Washington, District of Columbia; and 8Department of Medicine, Texas Tech University Health Science Center, El Paso, Texas

Submitted 30 January 2007 ; accepted in final form 21 March 2007

ABSTRACT

Telomeres are repetitive DNA sequences located at the ends of chromosomes. Telomeres are shortened by repeated cell divisions and by oxidative DNA damage, and cells with critically shortened telomeres cannot divide. We hypothesized that chronic gastroesophageal reflux disease (GERD)-induced injury of the esophageal squamous epithelium results in progressive telomeric shortening that eventually might interfere with mucosal healing. To address our hypothesis, we compared telomere length and telomerase activity in biopsy specimens of esophageal squamous epithelium from GERD patients and control patients. Endoscopic biopsies were taken from the esophageal squamous epithelium of 38 patients with GERD [10 long-segment Barrett's esophagus (LSBE), 15 short-segment (SSBE), 13 GERD without Barrett's esophagus] and 16 control patients without GERD. Telomere length was assessed using the terminal restriction fragment assay, and telomerase activity was studied by the PCR-based telomeric repeat amplification protocol assay. Patients with GERD had significantly shorter telomeres in the distal esophagus than controls [8.3 ± 0.5 vs. 10.9 ± 1.5 (SE) Kbp, P = 0.043]. Among the patients with GERD, telomere length in the distal esophagus did not differ significantly in those with and without Barrett's esophagus (LSBE 7.9 ± 0.8, SSBE 8.6 ± 0.9, GERD without BE 8.7 ± 1.0 Kbp). No significant differences in telomerase activity in the distal esophagus were noted between patients with GERD and controls (4.0 ± 0.39 vs. 5.2 ± 0.53 RIUs). Telomeres in the squamous epithelium of the distal esophagus of patients who have GERD, with and without Barrett's esophagus, are significantly shorter than those of patients without GERD despite similar levels of telomerase activity.

gastresophageal reflux disease; Barrett's esophagus; telomerase

AT THE 3' ENDS of all eukaryotic chromosomes are long regions of noncoding, repetitive DNA sequences called telomeres, which are needed to maintain normal chromosomal stability and function (3, 4, 6). During DNA replication, the cell's replication machinery cannot copy completely the 3' ends of chromosomes and, consequently, 50 to 200 bp of telomeric DNA are lost during each round of cell division (31). Oxidative damage can also shorten telomeres, which appear to be preferential sites for oxidative DNA injuries (11, 13, 22, 32). When telomeric shortening due to repeated cell divisions and oxidative damage reaches a certain critical level, it triggers exit from the cell cycle and entry into a permanent, growth-arrested state called senescence (1).

Telomeric shortening is judged to be the major intrinsic mechanism that ultimately limits the proliferative capacity of normal cells. Telomeric shortening from cell divisions and oxidative DNA damage can be halted if cells can express sufficient levels of telomerase, a cellular ribonucleoprotein enzyme that catalyzes the synthesis of new telomeric DNA (5). For some proliferating cells, telomerase expression prevents the critical telomeric shortening that otherwise would result in senescence.

A number of studies have shown that gastroesophageal reflux disease (GERD) increases proliferation in esophageal squamous cells (15, 34). Severe GERD is also associated with the generation of reactive oxygen species (ROS) that cause oxidative DNA damage in the esophageal squamous epithelium (23, 30, 33). The GERD-induced increase in cellular proliferation and oxidative DNA damage would be expected to result in shortened telomeres if the squamous cells are not able to produce sufficient levels of telomerase to counterbalance their loss of telomeric DNA.

We hypothesized that repeated cycles of GERD-induced injury and regeneration of esophageal squamous cells cause a progressive shortening of telomeres. It is possible that the GERD-induced loss of telomeric DNA might eventually reach a critical level that triggers senescence, thereby interfering with esophageal healing and promoting epithelial repair through alternative mechanisms like metaplasia. The aim of our study was to compare telomere length and telomerase activity in biopsy specimens of esophageal squamous epithelium from GERD patients and control patients.

MATERIALS AND METHODS

Study patients, endoscopic examination, and biopsy protocol. Patients scheduled for elective endoscopy at the Dallas VA Medical Center were invited to participate in the study. The study was approved by the IRB committee at the Dallas VA Medical Center and written informed consent was obtained from all patients. Patients were considered to have GERD if they had heartburn (off antireflux medications) at least once per month and/or endoscopic evidence of reflux esophagitis or Barrett's esophagus during the study endoscopic examination or during a previous endoscopic examination. Control patients had no heartburn and no endoscopic signs of reflux esophagitis or Barrett's esophagus.

During the endoscopic examination, reflux esophagitis was scored using the Los Angeles grading system (17). The gastroesophageal junction (GEJ) was identified as the most proximal extent of the gastric folds with the stomach partially inflated. Barrett's esophagus was suspected if columnar epithelium was seen to extend proximal to the GEJ, and confirmed if biopsy specimens of the esophageal columnar epithelium showed specialized intestinal metaplasia. Patients with Barrett's esophagus were further categorized as long-segment (LSBE) if specialized intestinal metaplasia extended ≥3 cm above the GEJ, and as short-segment (SSBE) if specialized intestinal metaplasia extended <3 cm above the GEJ. Biopsy specimens were taken for study purposes in all patients using jumbo biopsy forceps (Olympus FB-50K-1) as follows: 1) two specimens at the squamo-columnar junction (Z-line), 2) five specimens from the distal esophagus at 1 cm above the Z-line, 3) five specimens from the proximal esophagus at 20 cm from the incisor teeth, and 4) five specimens from the gastric fundus at 5 cm below the GEJ. The two specimens from the Z-line were used for histological evaluation only. For the other sets of five biopsy specimens, two were sent for histological evaluation and the other three were used for analyses of telomerase activity and telomere length.

Histological scoring of reflux esophagitis. Hematoxylin and eosin-stained slides of esophageal squamous epithelium were graded for inflammation by consensus of two pathologists (Y.S. and E.L.L.), who were blinded to clinical information [based on the number of eosinophils, lymphocytes, or neutrophils per high-power field (HPF)] as none (0 cells per HPF), mild (1 cell per HPF), moderate (2–5 cells per HPF), or severe (>5 cells per HPF).

Telomerase activity and telomere length analysis. Telomerase activity was studied using the PCR-based TRAP-eze Telomerase Detection kit (Intergen, Burlington, MA) as previously described (12). Briefly, 1 µg of protein isolated from frozen biopsy specimens was first incubated with a telomerase substrate Cy5-conjugated primer; an Internal Telomerase Activity Standard (ITAS) was included as the internal control. The telomerase-generated products and ITAS were amplified by PCR, and resolved on 10% nondenaturing acrylamide gels, which were exposed to a phosphor screen. Telomerase-generated products form a characteristic ladder pattern on these gels. The intensity of the telomeric signals (TRAP ladder) and ITAS was quantitated, and the relative telomerase activity was determined by comparing the area under the peaks of the TRAP ladder to the area under the ITAS peak. All image operations and calculations were performed with QuantityOne software and Microsoft Excel 5.0. HeLa cells and cell lysis buffer alone served as positive and negative controls, respectively.

Using a modification of Southern analysis, mean telomere length was estimated by telomere restriction fragment analysis as previously described (29). In short, genomic DNA isolated from frozen biopsy specimens was digested with a six-enzyme mixture comprising equal parts AluI, CfoI, HaeIII, HinfI, MspI, and RsaI (all from Roche). Digested samples (1–2 µg) were fractionated on a 0.7% agarose gel. The gel was denatured, dried, and hybridized with a 32P-labeled telomeric (CCCTAA)4 probe, complementary to the telomeric sequence. The gel was exposed on a PhosphorImager and mean telomere length was calculated using the program TELORUN provided by C. Harley, R. Allsopp, and H. Vaziri, as previously described (24).

Statistical analysis. Statistical comparisons of telomerase activities and telomere lengths between biopsy specimens from GERD patients and controls were performed using an unpaired Student's t-test using the Instat for Windows statistical software package (GraphPad Software). Statistical analyses of telomerase activity and telomere length of biopsy specimens and of patient characteristics between GERD and control patients with and without intestinal metaplasia were performed using an ANOVA using the Instat for Windows statistical software package (GraphPad Software). Statistical comparisons of telomerase activity between the gastric fundus and the distal and proximal esophagus within patient groups were performed using a paired ANOVA using the Instat for Windows statistical software package (GraphPad Software). P values of ≤0.05 were considered significant for all analyses.

RESULTS

Study population. The study population comprised 38 patients with GERD (including 15 patients with LSBE, 10 patients with SSBE, and 13 patients who had GERD without Barrett's esophagus) and 16 control patients. Clinical characteristics of the patients are shown in Table 1.


View this table:
[in this window]
[in a new window]

  		Table 1. Clinical characteristics of study patients

 
Telomere length in the distal squamous-lined esophagus is shorter in GERD patients than in controls. In the distal squamous-lined esophagus (1 cm proximal to the Z-line), mean telomere length was significantly shorter in the 38 patients with GERD than in the 16 control patients [8.3 ± 0.5 (SE) vs. 10.9 ± 1.5 Kbp, P = 0.043; Fig. 1]. No significant differences in mean telomere length were noted between GERD patients and controls for the proximal esophagus (GERD 9.4 ± 0.7, control 11.0 ± 1.5 Kbp) or for the gastric fundus (GERD 8.8 ± 0.4, controls 11.0 ± 1.5 Kbp).


Figure 1
View larger version (17K):
[in this window]
[in a new window]

  		Fig. 1. Mean telomere length in the distal esophageal squamous epithelium of gastroesophageal reflux disease (GERD) patients is significantly shorter than that of control patients. A: representative gels from esophageal biopsy specimens demonstrating telomere length. Note that telomere length in the distal esophagus of GERD patients is shorter than that of the control patients. D, distal; P, proximal; S, stomach. B: bar graph shows means ± SE telomere length of biopsies from GERD patients and controls. *P < 0.05.

 
We performed subgroup analyses to determine whether there is an association between Barrett's esophagus and the length of telomeres in the esophageal squamous epithelium. We found no significant differences in mean telomere lengths among patients who had GERD with and without Barrett's esophagus for the distal squamous-lined esophagus (SSBE 8.6 ± 0.9, LSBE 7.9 ± 0.8 SE, GERD without Barrett's esophagus 8.7 ± 1.0 Kbp; Fig. 2), for the proximal esophagus (SSBE 9.2 ± 1.5, LSBE 9.6 ± 1.2, GERD without Barrett's esophagus 9.3 ± 1.1 Kbp), or for the gastric fundus (SSBE 9.1 ± 1.2, LSBE 8.9 ± 0.68, GERD without Barrett's esophagus 8.4 ± 0.62 Kbp).


Figure 2
View larger version (24K):
[in this window]
[in a new window]

  		Fig. 2. Mean telomere length in the distal esophageal squamous epithelium does not differ significantly among GERD patients with short-segment Barrett's esophagus (SSBE), long-segment Barrett's esophagus (LSBE), or those without Barrett's esophagus. BE, Barrett's esophagus. A: representative gels from esophageal biopsy specimens demonstrating telomere length. B: bar graph shows means ± SE telomere length of biopsies from GERD patients with and without Barrett's esophagus.

 
Although our control patients had no symptoms of GERD and no endoscopic signs of esophagitis or Barrett's esophagus, biopsy specimens at the Z-line revealed intestinal metaplasia in 8 of the 16 patients. This condition is called intestinal metaplasia at the GEJ (IM at the GEJ), and its etiology is disputed (28). Whereas some authorities contend that this condition may be a manifestation of GERD, we performed subgroup analyses to determine whether there is an association between IM at the GEJ and the length of telomeres in the esophageal squamous epithelium. We found no significant differences in mean telomere lengths between control patients with and without IM at the GEJ for the distal esophagus (control 11.6 ± 2.1, control with IM 10.2 ± 2.2 Kbp), for the proximal esophagus (control 11.5 ± 2.5, control with IM 10.6 ± 2.0 Kbp), or for the gastric fundus (control 11.2 ± 2.4, control with IM 10.8 ± 1.8 Kbp).

Patients with GERD and control patients have similar levels of telomerase activity in the squamous-lined esophagus. Although patients with GERD had significantly shorter telomeres in the distal esophagus than control patients, we found no significant differences in telomerase activites between GERD patients and controls for the distal squamous esophagus [GERD 4.0 ± 0.39 (SE) relative intensity units (RIUs), control 5.2 ± 0.53 RIUs] (Fig. 3), for the proximal esophagus, or for the gastric fundus (data not shown). We also found no significant differences in telomerase activities at any site between control patients with and without IM at the GEJ (data not shown).


Figure 3
View larger version (8K):
[in this window]
[in a new window]

  		Fig. 3. Mean telomerase activity in distal esophageal squamous epithelium from GERD patients does not differ significantly from that of control patients. The bar graph shows means ± SE telomerase activity of biopsies from GERD patients and controls. NS, not significant.

 
Telomerase activities are lower in the gastric fundus than in the esophagus in both patient groups. Telomerase activities in the gastric fundus (GERD 0.38 ± 0.15, control 0.64 ± 0.24 RIUs) were significantly lower than those in the distal esophagus (GERD 4.0 ± 0.39, control 5.2 ± 0.53 RIUs) and in the proximal esophagus (GERD 5.3 ± 0.31, control 5.6 ± 0.55 RIUs) for both patient groups (P < 0.05; Fig. 4). There were no significant differences in telomerase activities in the esophagus and stomach between the two groups.


Figure 4
View larger version (21K):
[in this window]
[in a new window]

  		Fig. 4. Mean telomerase activity in the stomach is significantly less than that of the proximal and distal esophageal squamous epithelium in GERD patients and in control patients. A: representative gels from esophageal biopsy specimens demonstrating telomerase activity. –, Negative control; +, positive control; ITAS, internal telomerase activity standard. B: bar graph shows means ± SE telomerase activity of biopsies from the distal esophagus, proximal esophagus, and stomach from GERD patients and controls. *P < 0.05 compared with both the distal and proximal esophagus.

 
Endoscopic and histological esophagitis scores did not differ significantly between the two groups. We considered the possibility that telomere length and/or telomerase activity could vary with the severity of acute reflux esophagitis. At the time of endoscopy, however, the large majority of our GERD patients had been treated with antisecretory medications to control their reflux esophagitis (see Table 1). Consequently, we found no significant difference in the histological esophagitis scores between our GERD and control patients (GERD 1.7 ± 0.17, control 1.8 ± 0.28, P = 0.8).

DISCUSSION

Esophagitis due to GERD is most severe in the distal esophagus and infrequently involves the proximal esophagus. We found that telomeres in squamous cells from the distal esophagus of patients with GERD are significantly shorter than those of patients without GERD. In contrast, we found no significant differences in telomere lengths in the proximal esophagus of patients with and without GERD. These findings support our hypothesis that repeated bouts of GERD-induced injury result in a loss of telomeric DNA in the distal squamous-lined esophagus.

One mechanism whereby GERD may cause a loss of telomeric DNA in the distal esophagus is by increasing cellular proliferation, presumably as a result of peptic injury and inflammation. Telomeres are shortened by repeated cell divisions, and numerous studies have shown that GERD increases the proliferation rate of esophageal squamous cells. In a rat model of chronic GERD induced by esophagoduodenostomy, for example, the esophageal squamous epithelium exhibits an expanded basal proliferative zone with increased staining for the proliferation marker Ki-67 (34). In patients with severe reflux esophagitis, furthermore, biopsy specimens of esophageal squamous epithelium exhibit an expanded basal proliferative zone with increased uptake of tritiated thymidine (15).

Another mechanism whereby GERD may shorten telomeres is by generating ROS that cause oxidative damage to telomeric DNA. Elevated levels of ROS have been demonstrated in the esophageal squamous epithelium of patients with reflux esophagitis (33). In patients with severe GERD, furthermore, oxidative DNA damage has been demonstrated in the esophageal squamous epithelium by comet assay (which detects DNA strand breaks) and by the incorporation of the Fapy-DNA glycosylase enzyme (which detects 8-OHdG) (23). In a transgenic rat, which is engineered so that DNA mutations can be detected in vivo, the surgical induction of GERD has been shown to increase the frequency of DNA mutations in the esophageal squamous mucosa (30). Some studies also suggest that telomeres may be preferential sites for oxidative DNA injury (11, 13, 22, 32).

Telomerase is a riboneucleoprotein enzyme that catalyzes the synthesis of telomeric DNA by using an RNA component (hTR-human RNA telomerase) as a template and a telomerase catalytic (hTERT-human telomerase reverse transcriptase) subunit protein to add repetitive DNA sequences to the 3' ends of chromosomes (7, 19). In some proliferating cells, telomerase expression may compensate for the progressive telomere loss that eventually would lead to replicative senescence. Although our GERD patients exhibited shortened telomeres in the distal esophagus, we found no significant differences in esophageal telomerase activities between patients with and without GERD. This suggests that the decreased telomere length in GERD patients did not result from decreased telomerase activity. Nevertheless, it is conceivable that the "normal" levels of telomerase in GERD patients may not be sufficient to prevent the progressive loss of telomeric DNA. In other words, an upregulation of telomerase activity might be required to prevent telomere shortening in patients with chronic GERD.

We did find that telomerase activities in the gastric fundus were significantly lower than those in the proximal and distal esophagus in both GERD and control patients. Telomerase activity is found in epithelial cells that maintain their proliferative capacities, whereas telomerase activity usually is absent in connective tissues (2, 10). Therefore, when determining telomerase activity in mucosal biopsy specimens, the presence of submucosal connective tissues that are devoid of the enzyme can result in an underestimation of epithelial telomerase activity. Whereas we have noted that endoscopic biopsy specimens of the stomach may contain more submucosal tissue than those of the esophagus, some of the difference in telomerase activity levels between the two organs may be spurious (i.e., the result of greater contamination of the gastric specimens with telomerase-poor submucosal tissues). Nevertheless, our findings are consistent with those of Bachor et al. (2) who also observed lower telomerase activities in endoscopic biopsy specimens taken from the stomach than in those obtained from the squamous-lined esophagus. Furthermore, the magnitude of the difference between gastric and esophageal telomerase activities appears to be too large to be explained by submucosal contamination alone. The explanation for the differences in telomerase activities between these two gastrointestinal organs is not known.

We considered the possibility that the telomere shortening that we observed in our GERD patients might have been the result of advanced age. Telomere lengths are known to decrease with age, but the ages of our patients and control patients did not differ significantly (9, 14). We also considered the possibility that acute reflux esophagitis might cause confounding effects on telomere length and telomerase levels. At the time of endoscopy, however, the large majority of our GERD patients had been treated with antisecretory medications to control their reflux esophagitis. Thus we found no differences in the degree of histological grade of esophagitis between the GERD patients and controls.

In most patients with reflux esophagitis, the peptic esophageal injury heals through the regeneration of more squamous cells. In some, however, healing occurs through a metaplastic process in which an abnormal, intestinal-type epithelium replaces the injured squamous one. This condition is called Barrett's esophagus, and the metaplastic cells of Barrett's esophagus are predisposed to develop adenocarcinoma (27). It is not known why only a minority of patients with GERD develop Barrett's esophagus. We found significantly shortened telomeres in the distal esophagus of patients with GERD. We speculate that esophageal squamous cells with critically shortened telomeres may become senescent and unable to regenerate in response to further peptic injury. This situation might favor mucosal healing through alternative mechanisms such as metaplasia.

Several studies found that telomeres in Barrett's metaplasia are shorter than those in the stomach (8, 18, 21). Despite the finding of short telomeres, biopsy specimens of metaplastic Barrett's epithelium exhibit higher levels of mRNA expression for the telomerase reverse transcriptase catalytic subunit (TERT) than normal squamous epithelium (16). Using in situ hybridization, Morales et al. (20) found expression of telomerase RNA in benign Barrett's epithelium in up to 70% of cases. They also found that increased telomerase expression correlated with the degree of dysplasia, with strong expression demonstrated in 100% of cases with high grade dysplasia and adenocarcinoma in Barrett's esophagus. Furthermore, inhibition of telomerase in Barrett's cancer cells in vitro leads to telomeric shortening, senescence, and apoptosis, suggesting that telomerase expression is essential for the survival of Barrett's cancer cells (25, 26).

To the best of our knowledge, ours is the first study to evaluate systematically the telomere length and telomerase activity in the squamous esophagus of patients with GERD, with and without Barrett's esophagus. A subgroup analysis of our GERD patients revealed no significant differences in squamous cell telomere length among those with long- and short-segment Barrett's esophagus and those who had GERD without Barrett's esophagus. Thus it is not clear that telomere shortening contributes to the pathogenesis of Barrett's esophagus. Nevertheless, further studies on this issue are clearly warranted.

GRANTS

This work was supported by the Office of Medical Research, Department of Veteran's Affairs (R. F. Souza, R. D. Ramirez), National Institutes of Health Grant DK-63621 to R. F. Souza, the Harris Methodist Health Foundation, Dr. Clark R. Gregg Fund (R. F. Souza, R. D. Ramirez), and Investigator-Sponsored Study Program of Astra Zeneca (S. J. Spechler).

FOOTNOTES


Address for reprint requests and other correspondence: R. F. Souza, Dept. of GI, MC#111B1, Dallas VA Medical Center, 4500 South Lancaster Road, Dallas, TX 75216 (e-mail: Rhonda.Souza{at}UTSouthwestern.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

REFERENCES

  1. Allsopp RC, Harley CB. Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 219: 130–136, 1995.[CrossRef][Web of Science][Medline]
  2. Bachor C, Bachor OA, Boukamp P. Telomerase is active in normal gastrointestinal mucosa and not upregulated in precancerous lesions. J Cancer Res Clin Oncol 125: 453–460, 1999.[CrossRef][Web of Science][Medline]
  3. Baur JA, Zou Y, Shay JW, Wright WE. Telomere position effect in human cells. Science 292: 2075–2077, 2001.[Abstract/Free Full Text]
  4. Biessmann H, Mason JM. Genetics and molecular biology of telomeres. Adv Genet 30: 185–249, 1992.[Web of Science][Medline]
  5. Blackburn EH. Structure and function of telomeres. Nature 350: 569–573, 1991.[CrossRef][Medline]
  6. De Lange T. Human telomeres are attached to the nuclear matrix. EMBO J 11: 717–724, 1992.[Web of Science][Medline]
  7. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J. The RNA component of human telomerase. Science 269: 1236–1241, 1995.[Abstract/Free Full Text]
  8. Finley JC, Reid BJ, Odze RD, Sanchez CA, Galipeau P, Li X, Self SG, Gollahon KA, Blount PL, Rabinovitch PS. Chromosomal instability in Barrett's esophagus is related to telomere shortening. Cancer Epidemiol Biomarkers Prev 15: 1451–1457, 2006.[Abstract/Free Full Text]
  9. Granger MP, Wright WE, Shay JW. Telomerase in cancer and aging. Crit Rev Oncol Hematol 41: 29–40, 2002.[Web of Science][Medline]
  10. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 93: 6476–6481, 1996.[Abstract/Free Full Text]
  11. Henle ES, Han Z, Tang N, Rai P, Luo Y, Linn S. Sequence-specific DNA cleavage by Fe2+-mediated fenton reactions has possible biological implications. J Biol Chem 274: 962–971, 1999.[Abstract/Free Full Text]
  12. Holt SE, Norton JC, Wright WE. Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Methods in Cell Science 18: 237–248, 1996.[CrossRef]
  13. Kruk PA, Rampino NJ, Bohr VA. DNA damage and repair in telomeres: relation to aging. Proc Natl Acad Sci USA 92: 258–262, 1995.[Abstract/Free Full Text]
  14. Lindsey J, McGill NI, Lindsey LA, Green DK, Cooke HJ. In vivo loss of telomeric repeats with age in humans. Mutat Res 256: 45–48, 1991.[CrossRef][Web of Science][Medline]
  15. Livstone EM, Sheahan DG, Behar J. Studies of esophageal epithelial cell proliferation in patients with reflux esophagitis. Gastroenterology 73: 1315–1319, 1977.[Web of Science][Medline]
  16. Lord RV, Salonga D, Danenberg KD, Peters JH, DeMeester TR, Park JM, Johansson J, Skinner KA, Chandrasoma P, DeMeester SR, Bremner CG, Tsai PI, Danenberg PV. Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. J Gastrointest Surg 4: 135–142, 2000.[CrossRef][Web of Science][Medline]
  17. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, Hongo M, Richter JE, Spechler SJ, Tytgat GN, Wallin L. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 45: 172–180, 1999.[Abstract/Free Full Text]
  18. Meeker AK, Hicks JL, Iacobuzio-Donahue CA, Montgomery EA, Westra WH, Chan TY, Ronnett BM, De Marzo AM. Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin Cancer Res 10: 3317–3326, 2004.[Abstract/Free Full Text]
  19. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA. hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells and during immortalization. Cell 90: 785–795, 1997.[CrossRef][Web of Science][Medline]
  20. Morales CP, Lee EL, Shay JW. In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer 83: 652–659, 1998.[CrossRef][Web of Science][Medline]
  21. O'Sullivan JN, Finley JC, Risques RA, Shen WT, Gollahon KA, Moskovitz AH, Gryaznov S, Harley CB, Rabinovitch PS. Telomere length assessment in tissue sections by quantitative FISH: image analysis algorithms. Cytometry 58: 120–131, 2004.[Medline]
  22. Oikawa S, Kawanishi S. Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening. FEBS Lett 453: 365–368, 1999.[CrossRef][Web of Science][Medline]
  23. Olliver JR, Hardie LJ, Dexter S, Chalmers D, Wild CP. DNA damage levels are raised in Barrett's oesophageal mucosa relative to the squamous epithelium of the oesophagus. Biomarkers 8: 509–521, 2003.[CrossRef][Web of Science][Medline]
  24. Ouellette MM, Liao M, Herbert BS, Johnson M, Holt SE, Liss HS, Shay JW, Wright WE. Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase. J Biol Chem 275: 10072–10076, 2000.[Abstract/Free Full Text]
  25. Shammas MA, Koley H, Batchu RB, Bertheau RC, Protopopov A, Munshi NC, Goyal RK. Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential. Mol Cancer 4: 24, 2005.[CrossRef][Medline]
  26. Shammas MA, Koley H, Beer DG, Li C, Goyal RK, Munshi NC. Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitor. Gastroenterology 126: 1337–1346, 2004.[CrossRef][Web of Science][Medline]
  27. Spechler SJ. Clinical practice. Barrett's esophagus. N Engl J Med 346: 836–842, 2002.[Free Full Text]
  28. Spechler SJ. Intestinal metaplasia at the gastroesophageal junction. Gastroenterology 126: 567–575, 2004.[CrossRef][Web of Science][Medline]
  29. Steinert S, Shay JW, Wright WE. Transient expression of human telomerase extends the life span of normal human fibroblasts. Biochem Biophys Res Commun 273: 1095–1098, 2000.[CrossRef][Web of Science][Medline]
  30. Theisen J, Peters JH, Fein M, Hughes M, Hagen JA, DeMeester SR, DeMeester TR, Laird PW. The mutagenic potential of duodenoesophageal reflux. Ann Surg 241: 63–68, 2005.[Web of Science][Medline]
  31. Von Zglinicki T. Role of oxidative stress in telomere length regulation and replicative senescence. Ann NY Acad Sci 908: 99–110, 2000.[Web of Science][Medline]
  32. Von Zglinicki T, Pilger R, Sitte N. Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts. Free Radic Biol Med 28: 64–74, 2000.[CrossRef][Web of Science][Medline]
  33. Wetscher GJ, Hinder RA, Bagchi D, Hinder PR, Bagchi M, Perdikis G, McGinn T. Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am J Surg 170: 552–556, 1995.[CrossRef][Web of Science][Medline]
  34. Zhang F, Altorki NK, Wu YC, Soslow RA, Subbaramaiah K, Dannenberg AJ. Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids. Gastroenterology 121: 1391–1399, 2001.[CrossRef][Web of Science][Medline]



This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
R. A. Risques, T. L. Vaughan, X. Li, R. D. Odze, P. L. Blount, K. Ayub, J. L. Gallaher, B. J. Reid, and P. S. Rabinovitch
Leukocyte Telomere Length Predicts Cancer Risk in Barrett's Esophagus
Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2649 - 2655.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/1/G19    most recent
00055.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Souza, R. F.
Right arrow Articles by Spechler, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Souza, R. F.
Right arrow Articles by Spechler, S. J.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.